医薬品有効成分(API)の世界市場2021年-2025年

◆英語タイトル:Global Active Pharmaceutical Ingredients Market 2021-2025
◆商品コード:IRTNTR40608
◆発行会社(リサーチ会社):Technavio
◆発行日:2021年1月28日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:アジア太平洋、北米、ヨーロッパ、その他の地域
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

テクナビオ社の本調査レポートでは、世界の医薬品有効成分(API)市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製造タイプ別(キャプティブAPI、コントラクトAPI)分析、顧客状況、地域別状況、企業状況、企業分析などの項目を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の医薬品有効成分(API)市場規模:製造タイプ別(キャプティブAPI、コントラクトAPI)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Active Pharmaceutical Ingredients Market 2021-2025
Technavio has been monitoring the active pharmaceutical ingredients market and it is poised to grow by $ 64.53 bn during 2021-2025, progressing at a CAGR of 6% during the forecast period. Our report on the active pharmaceutical ingredients market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the evolving API manufacturing scenario in developing countries and the growing need to focus on core competencies. In addition, evolving API manufacturing scenario in developing countries is anticipated to boost the growth of the market as well.
The active pharmaceutical ingredients market analysis includes type segment and geographical landscapes.
Technavio’s active pharmaceutical ingredients market is segmented as below:

By Type
Captive APIs
Contract APIs

By Geography
APAC
North America
Europe
ROW

This study identifies the Increasing number of type II DMFs as one of the prime reasons driving the active pharmaceutical ingredients market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the active pharmaceutical ingredients market covers the following areas:
Active pharmaceutical ingredients market sizing
Active pharmaceutical ingredients market forecast
Active pharmaceutical ingredients market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading active pharmaceutical ingredients market vendors that include Amneal Pharmaceuticals Inc., Cadila Healthcare Ltd., GlaxoSmithKline Plc, Koninklijke DSM NV, Mylan NV, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the active pharmaceutical ingredients market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/active-pharmaceutical-ingredients-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Manufacturing Type
o Market segments
o Comparison by manufacturing type
o Captive APIs – Market size and forecast 2020-2025
o Contract APIs – Market size and forecast 2020-2025
o Market opportunity by manufacturing type
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o APAC – Market size and forecast 2020-2025
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
 Competitive scenario
 Vendor landscape
 Landscape disruption
• Vendor Analysis
 Vendors covered
 Market positioning of vendors
 Amneal Pharmaceuticals Inc.
 Cadila Healthcare Ltd.
 Dr. Reddy’s Laboratories Ltd.
 GlaxoSmithKline Plc
o Koninklijke DSM NV
o Mylan NV
o Novartis AG
o Pfizer Inc.
o Sun Pharmaceutical Industries Ltd.
o Teva Pharmaceutical Industries Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ billion)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: Other1 – Market share 2020-2025 (%)
• 22: Comparison by Other1
• 23: Captive APIs – Market size and forecast 2020-2025 ($ billion)
• 24: Captive APIs – Year-over-year growth 2020-2025 (%)
• 25: Contract APIs – Market size and forecast 2020-2025 ($ billion)
• 26: Contract APIs – Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Other1
• 28: Customer landscape
• 29: Market share by geography 2020-2025 (%)
• 30: Geographic comparison
• 31: APAC – Market size and forecast 2020-2025 ($ billion)
• 32: APAC – Year-over-year growth 2020-2025 (%)
• 33: North America – Market size and forecast 2020-2025 ($ billion)
• 34: North America – Year-over-year growth 2020-2025 (%)
• 35: Europe – Market size and forecast 2020-2025 ($ billion)
• 36: Europe – Year-over-year growth 2020-2025 (%)
• 37: ROW – Market size and forecast 2020-2025 ($ billion)
• 38: ROW – Year-over-year growth 2020-2025 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ billion)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Amneal Pharmaceuticals Inc. – Overview
• 48: Amneal Pharmaceuticals Inc. – Business segments
• 49: Amneal Pharmaceuticals Inc. – Key offerings
• 50: Amneal Pharmaceuticals Inc. – Key customers
• 51: Amneal Pharmaceuticals Inc. – Segment focus
• 52: Cadila Healthcare Ltd. – Overview
• 53: Cadila Healthcare Ltd. – Business segments
• 54: Cadila Healthcare Ltd. – Key offerings
• 55: Cadila Healthcare Ltd. – Key customers
• 56: Cadila Healthcare Ltd. – Segment focus
• 57: GlaxoSmithKline Plc – Overview
• 58: GlaxoSmithKline Plc – Business segments
• 59: GlaxoSmithKline Plc – Key offerings
• 60: GlaxoSmithKline Plc – Key customers
• 61: GlaxoSmithKline Plc – Segment focus
• 62: Koninklijke DSM NV – Overview
• 63: Koninklijke DSM NV – Business segments
• 64: Koninklijke DSM NV – Key offerings
• 65: Koninklijke DSM NV – Key customers
• 66: Koninklijke DSM NV – Segment focus
• 67: Mylan NV – Overview
• 68: Mylan NV – Business segments
• 69: Mylan NV – Key offerings
• 70: Mylan NV – Key customers
• 71: Mylan NV – Segment focus
• 72: Novartis AG – Overview
• 73: Novartis AG – Business segments
• 74: Novartis AG – Key offerings
• 75: Novartis AG – Key customers
• 76: Novartis AG – Segment focus
• 77: Pfizer Inc. – Overview
• 78: Pfizer Inc. – Business segments
• 79: Pfizer Inc. – Key offerings
• 80: Pfizer Inc. – Key customers
• 81: Pfizer Inc. – Segment focus
• 82: Sun Pharmaceutical Industries Ltd. – Overview
• 83: Sun Pharmaceutical Industries Ltd. – Business segments
• 84: Sun Pharmaceutical Industries Ltd. – Key offerings
• 85: Sun Pharmaceutical Industries Ltd. – Key customers
• 86: Sun Pharmaceutical Industries Ltd. – Segment focus
• 87: Teva Pharmaceutical Industries Ltd. – Overview
• 88: Teva Pharmaceutical Industries Ltd. – Business segments
• 89: Teva Pharmaceutical Industries Ltd. – Key offerings
• 90: Teva Pharmaceutical Industries Ltd. – Key customers
• 91: Teva Pharmaceutical Industries Ltd. – Segment focus
• 92: Currency conversion rates for US$
• 93: Research Methodology
• 94: Validation techniques employed for market sizing
• 95: Information sources
• 96: List of abbreviations



【掲載企業】

Amneal Pharmaceuticals Inc., Cadila Healthcare Ltd., GlaxoSmithKline Plc, Koninklijke DSM NV, Mylan NV, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[医薬品有効成分(API)の世界市場2021年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆